This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liu, W.-M. Articles by Kohwi-Shigematsu, T. Search for Related Content PubMed PubMed Citation Articles by Liu, W.-M. Articles by Kohwi-Shigematsu, T.

HMG-I(Y) Recognizes Base-unpairing Regions of Matrix Attachment Sequences and Its Increased Expression Is Directly Linked to Metastatic Breast Cancer Phenotype¹

Lawrence Berkeley National Laboratory, University of California, Berkeley, California 94720 [W-M. L., F. K. G-V., R L., T. K-S.]; and Biological Research Laboratories, Sankyo Co., Ltd, Shinagawa-ku, Tokyo 140, Japan [S. K.]

Base-unpairing regions (BURs) contain a specialized DNA context with an exceptionally high unwinding propensity, and are typically identified within various matrix attachment regions. A BUR affinity column was used to purify a doublet of M_r 20,000 proteins from human breast carcinoma cells. These proteins were identified as the high-mobility group (HMG) protein, HMG-I, and its splicing variant, HMG-Y. We show that HMG-I(Y) specifically binds BURs. Mutating BURs so as to abrogate their unwinding property greatly reduced their binding affinity to HMG-I(Y). Numerous studies have indicated that elevated HMG-I(Y) expression is correlated with more advanced cancers and with increased metastatic potential. We studied whether the expression of HMG-I(Y) responds to signaling through the heregulin (HRG)-erbB pathway and the extracellular matrix. HMG-I(Y) expression was increased in MCF-7 cells after stable transfection with an HRG expression construct that led cells to acquire estrogen independence and metastasizing ability. A high level of HMG-I(Y) expression was detected in metastatic MDA-MB-231 cells, but the expression was virtually diminished, and the metastasizing ability was lost after cells were stably transfected with an antisense HRG cDNA construct. HMG-I(Y) was also decreased in MDA-MB-231 cells when treated with a chemical inhibitor for matrix metalloproteinase-9 that led to a reduction of invasive capability in vitro. The level of HMG-I(Y) expression, therefore, is dynamically regulated in human breast cancer cells in response to varying types of signaling that affect metastatic ability, including the HRG-erbB pathway and those from the extracellular matrix.

This article has been cited by other articles:

				I. Cleynen, C. Huysmans, T. Sasazuki, S. Shirasawa, W. Van de Ven, and K. Peeters Transcriptional Control of the Human High Mobility Group A1 Gene: Basal and Oncogenic Ras-Regulated Expression Cancer Res., May 15, 2007; 67(10): 4620 - 4629. [Abstract] [Full Text] [PDF]

				S.-S. Liau, A. Jazag, and E. E. Whang HMGA1 Is a Determinant of Cellular Invasiveness and In vivo Metastatic Potential in Pancreatic Adenocarcinoma Cancer Res., December 15, 2006; 66(24): 11613 - 11622. [Abstract] [Full Text] [PDF]

				A. Jalota, K. Singh, L. Pavithra, R. Kaul-Ghanekar, S. Jameel, and S. Chattopadhyay Tumor Suppressor SMAR1 Activates and Stabilizes p53 through Its Arginine-Serine-rich Motif J. Biol. Chem., April 22, 2005; 280(16): 16019 - 16029. [Abstract] [Full Text] [PDF]

				M Lacroix, R-A Toillon, and G Leclercq Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics Endocr. Relat. Cancer, September 1, 2004; 11(3): 497 - 522. [Abstract] [Full Text] [PDF]

				G. Baldassarre, S. Battista, B. Belletti, S. Thakur, F. Pentimalli, F. Trapasso, M. Fedele, G. Pierantoni, C. M. Croce, and A. Fusco Negative Regulation of BRCA1 Gene Expression by HMGA1 Proteins Accounts for the Reduced BRCA1 Protein Levels in Sporadic Breast Carcinoma Mol. Cell. Biol., April 1, 2003; 23(7): 2225 - 2238. [Abstract] [Full Text] [PDF]

				D. B. Rubinstein, A. Stortchevoi, M. Boosalis, R. Ashfaq, and T. Guillaume Overexpression of DNA-binding Protein B Gene Product in Breast Cancer as Detected by in Vitro-generated Combinatorial Human Immunoglobulin Libraries Cancer Res., September 1, 2002; 62(17): 4985 - 4991. [Abstract] [Full Text] [PDF]

				N. Takaha, A. L. Hawkins, C. A. Griffin, W. B. Isaacs, and D. S. Coffey High Mobility Group Protein I(Y): A Candidate Architectural Protein for Chromosomal Rearrangements in Prostate Cancer Cells Cancer Res., February 1, 2002; 62(3): 647 - 651. [Abstract] [Full Text] [PDF]

				M. Fedele, S. Battista, G. Manfioletti, C. M. Croce, V. Giancotti, and A. Fusco Role of the high mobility group A proteins in human lipomas Carcinogenesis, October 1, 2001; 22(10): 1583 - 1591. [Abstract] [Full Text] [PDF]

				R. Reeves, D. D. Edberg, and Y. Li Architectural Transcription Factor HMGI(Y) Promotes Tumor Progression and Mesenchymal Transition of Human Epithelial Cells Mol. Cell. Biol., January 15, 2001; 21(2): 575 - 594. [Abstract] [Full Text]

				J. D. Alvarez, D. H. Yasui, H. Niida, T. Joh, D. Y. Loh, and T. Kohwi-Shigematsu The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development Genes & Dev., March 1, 2000; 14(5): 521 - 535. [Abstract] [Full Text]

				F. Diana, R. Sgarra, G. Manfioletti, A. Rustighi, D. Poletto, M. T. Sciortino, A. Mastino, and V. Giancotti A Link between Apoptosis and Degree of Phosphorylation of High Mobility Group A1a Protein in Leukemic Cells J. Biol. Chem., March 30, 2001; 276(14): 11354 - 11361. [Abstract] [Full Text] [PDF]